Zobrazeno 1 - 8
of 8
pro vyhledávání: '"C S Coffin"'
Autor:
Z Lee, S Nishikawa, S Gao, J B Eksteen, M Czub, M J Gill, C Osiowy, F van der Meer, G van Marle, C S Coffin
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137568 (2015)
The hepatitis B virus (HBV) and the human immunodeficiency virus type 1 (HIV-1) can infect cells of the lymphatic system. It is unknown whether HIV-1 co-infection impacts infection of peripheral blood mononuclear cell (PBMC) subsets by the HBV.To com
Externí odkaz:
https://doaj.org/article/4074bad5c7ac42d094230908b6fc62b9
Autor:
L Al-Yasiri, R P Davis, S D'souza, T R Patel, F van der Meer, D P Whiteside, T I Michalak, C N Jenne, C S Coffin
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 6:69-70
Background Hepatitis B virus (HBV) infections are one of the largest global infectious disease burdens, despite the availability of a preventative vaccine. The virus infects the liver which is a vital organ that plays a critical role in homeostasis d
Autor:
S H Rahman, Y Scharr, J Jeyaparan, A Manko, C S Coffin, S E Congly, A Ramji, S Fung, C Cooper, M Ma, R Bailey, G Minuk, A Wong, K Doucette, M Elkhashab, P Wong, M Brahmania
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 5:106-107
Background Chronic hepatitis B (CHB) is the most common cause of hepatocellular carcinoma (HCC) worldwide. Aims The primary aim of this study is to explore the degree of treatment adherence to the American Association For The Study of Liver Disease (
BACKGROUND: Current guidelines recommend HCC surveillance in certain chronic HBV carriers: Asian male age > 40, Asian female age > 50, African/Non-African blacks, family history of HCC and cirrhosis. AIMS: To determine the HCC screening practices amo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63e439add0e77aeb0998d62e987ecd0d
https://europepmc.org/articles/PMC6507861/
https://europepmc.org/articles/PMC6507861/
Autor:
C R, O'neil, C S, Coffin
Publikováno v:
Minerva gastroenterologica e dietologica. 60(3)
With the success of highly active antiretroviral therapy in treating HIV, liver disease has emerged as a major cause of morbidity and mortality amongst HCV and HIV coinfected patients. Until recently, the treatment of HCV in HIV positive patients wit
Publikováno v:
Journal of viral hepatitis. 19(2)
Hepatitis C virus (HCV) and hepatitis B virus (HBV) frequently coinfect and persist long after clinical resolution. We assessed the incidence of low-level (occult) HCV infection (OCI) after sustained virological response (SVR) to standard anti-HCV th
Autor:
C S, Coffin, P M, Mulrooney-Cousins, M G, Peters, G, van Marle, J P, Roberts, T I, Michalak, N A, Terrault
Publikováno v:
Journal of viral hepatitis. 18(6)
The hepatitis B virus (HBV) replicates via an error-prone reverse transcriptase generating potential drug-resistant quasispecies. The degree of HBV variability in liver vs peripheral blood mononuclear cells (PBMC) in patients on long-term suppressive
Autor:
C S, Coffin, P G, Stock, L M, Dove, C L, Berg, N N, Nissen, M P, Curry, M, Ragni, F G, Regenstein, K E, Sherman, M E, Roland, N A, Terrault
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 10(5)
Liver transplantation (LT) is the treatment of choice for end-stage liver disease, but is controversial in patients with human immunodeficiency virus (HIV) infection. Using a prospective cohort of HIV-hepatitis B virus (HBV) coinfected patients trans